Axcella Health Stock Debt To Equity
| AXLADelisted Stock | USD 0.20 0.02 11.11% |
Axcella Health fundamentals help investors to digest information that contributes to Axcella Health's financial success or failures. It also enables traders to predict the movement of Axcella Stock. The fundamental analysis module provides a way to measure Axcella Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axcella Health stock.
Axcella |
Axcella Health Company Debt To Equity Analysis
Axcella Health's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Axcella Health Debt To Equity | 3.02 % |
Most of Axcella Health's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axcella Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Axcella Health has a Debt To Equity of 3.017%. This is 94.36% lower than that of the Biotechnology sector and 84.42% lower than that of the Health Care industry. The debt to equity for all United States stocks is 93.8% higher than that of the company.
Axcella Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axcella Health's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axcella Health could also be used in its relative valuation, which is a method of valuing Axcella Health by comparing valuation metrics of similar companies.Axcella Health is currently under evaluation in debt to equity category among its peers.
Axcella Fundamentals
| Return On Equity | -13.7 | |||
| Return On Asset | -0.88 | |||
| Current Valuation | 1.94 M | |||
| Shares Outstanding | 2.95 M | |||
| Shares Owned By Insiders | 15.77 % | |||
| Shares Owned By Institutions | 66.67 % | |||
| Number Of Shares Shorted | 78.18 K | |||
| Price To Earning | (1.10) X | |||
| Price To Book | 8.74 X | |||
| EBITDA | (67.01 M) | |||
| Net Income | (81.19 M) | |||
| Cash And Equivalents | 44.4 M | |||
| Cash Per Share | 0.84 X | |||
| Total Debt | 2.16 M | |||
| Debt To Equity | 3.02 % | |||
| Current Ratio | 2.69 X | |||
| Book Value Per Share | (0.77) X | |||
| Cash Flow From Operations | (69.59 M) | |||
| Short Ratio | 0.75 X | |||
| Earnings Per Share | (18.25) X | |||
| Target Price | 10.62 | |||
| Number Of Employees | 11 | |||
| Beta | 1.01 | |||
| Market Capitalization | 13.5 M | |||
| Total Asset | 18.93 M | |||
| Retained Earnings | (418.43 M) | |||
| Working Capital | 3.88 M | |||
| Current Asset | 61.65 M | |||
| Current Liabilities | 6.16 M | |||
| Z Score | -38.64 | |||
| Net Asset | 18.93 M |
About Axcella Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Axcella Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axcella Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axcella Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Axcella Stock
If you are still planning to invest in Axcella Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axcella Health's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |